TheEdgeResearch
Home / Stocks / PHBI

Pharmagreen Biotech Inc. (PHBI)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▼ -44.44%
Market Cap
$345,673
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.75
52-Wk Range
0.0003-0.0035
CEO
Peter Wojcik
Country
CA
Currency
USD

Pharmagreen Biotech Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Coquitlam, BC, CA. The stock last traded at $0.00, down 44.44% on the session, giving a market capitalisation of $345,673. On trailing twelve-month figures it carries a trailing P/E of -0.23, a net margin of -29.1%. Its beta of 1.75 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.23
Price / Sales
0.08
Price / Book
-0.04
EV / EBITDA
-0.30
Gross margin
-0.0%
Operating margin
-31.6%
Net margin
-29.1%
Return on equity
Debt / equity
-0.03
Current ratio
0.07
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2018-08-15
Headquarters
Coquitlam, BC, CA
About Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.

Comparable companies

Pharmagreen Biotech Inc. is most often compared with the following Healthcare names:

ALIDAPPBCBDYCNNACPMDEXMTLVVEFMJNAMSTHSRUTF
More research on PHBI
PHBI technical analysis PHBI TheEdge Score Compare against peers
Open full interactive analysis & DCF →